Covered recipient · General Payments record
TAYLOR M LEWALLEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$602.08
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $540.25 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $244.73 | 18 |
| Acerta Pharma LLC | $219.16 | 7 |
| PFIZER INC. | $30.44 | 2 |
| Novo Nordisk AS | $27.59 | 2 |
| Radius Health, Inc. | $18.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.58 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533609 | CMS |
| ABBVIE INC. | $11.85 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533611 | CMS |
| ABBVIE INC. | $4.15 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533613 | CMS |
| ABBVIE INC. | $23.10 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533615 | CMS |
| ABBVIE INC. | $9.25 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533617 | CMS |
| ABBVIE INC. | $13.56 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533619 | CMS |
| ABBVIE INC. | $15.74 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533621 | CMS |
| ABBVIE INC. | $30.78 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533623 | CMS |
| ABBVIE INC. | $8.66 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533625 | CMS |
| ABBVIE INC. | $31.86 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533627 | CMS |
| ABBVIE INC. | $9.05 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533629 | CMS |
| ABBVIE INC. | $13.17 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533631 | CMS |
| ABBVIE INC. | $9.67 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533633 | CMS |
| ABBVIE INC. | $6.51 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533635 | CMS |
| ABBVIE INC. | $11.44 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533637 | CMS |
| ABBVIE INC. | $3.59 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533639 | CMS |
| ABBVIE INC. | $13.44 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533641 | CMS |
| ABBVIE INC. | $16.33 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107533643 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.47 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110533222 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.71 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110555690 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.41 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110535220 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.60 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110554444 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.93 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110536458 | CMS |
| AstraZeneca Pharmaceuticals LP | $117.49 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110540127 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.55 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110540021 | CMS |
| Novo Nordisk Inc | $13.76 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570608 | CMS |
| Novo Nordisk Inc | $13.83 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108572620 | CMS |
| PFIZER INC. | $15.71 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131076647 | CMS |
| PFIZER INC. | $14.73 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131747264 | CMS |
| Radius Health, Inc. | $18.33 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090043156 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.